Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-5942

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-5942). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figr1 (Figr1)

This text appears to be a list of drugs and their interactions with other drugs, as well as their effects on certain analytes. The text also provides PK Fold Change and 90% CI Recommendation for each pair of drugs. Additionally, the text includes recommendations for the use of certain drugs with caution or avoidance due to potential side effects or unknown clinical significance.*

FDA Label Image

Figr2 (Figr2)

This appears to be a table showing the interaction of various drugs and their effect on PKFold change with respect to the active moiety. It also shows the Cmax and AUC values for each drug. The table also provides recommendations on the use of drugs, such as whether to avoid concomitant use, dose adjustment, or use caution and monitor blood pressure.*

FDA Label Image

Figr3 (Figr3)

This is a table of recommendations for adjusting the dosing of the antidepressant drug venlafaxine in certain special populations, based on measurements of PK (pharmacokinetics) and fold change (compared to a reference value). These special populations include individuals with hepatic impairment (mild, moderate, or cirrhosis), renal impairment (hemodialysis), CYP2D6 polymorphism, age over 60 years, and different genders. The recommendations suggest reducing the dose by various amounts or individualizing dosing based on the measurements.*

FDA Label Image

Label Image (Lbl500905942)

This is a medication label for a product called "YENLArAxTvE Hydrochloride", with each extended-release capsule containing 37.5 mg of the active ingredient. The label includes instructions to store the medication at a specific temperature range and indicates that it comes in a bottle with 30 capsules.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.